Clinical Trial Update: Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing GP40081 to NovoMix 30 FlexPen in type 2 diabetes mellitus evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GP40081
• NovoMix 30 FlexPen (insulin lispro protamine suspension)

Snippet

Sponsor: Geropharm | Conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus | Phase 3 | Status: UNKNOWN